Concepedia

Author

Anna Fábián

University of SzegedORCID

Also Known As

A FABIAN, A Fabian, A Fbin, A Fábián, A. Fabian, A. Fábián, Ann-Sofie Backman, Anna Fabian, Anna FÁBIÁN, Anna FábiáN

146

Publications

800

Citations

15

H-Index

21

Concepts

All Affiliations

University of SzegedSemmelweis UniversityHumanitas UniversityUniversity of PecsCharles University
AF

About

Anna Fábián is an author at University of Szeged specializing in medicine, gastroenterology, and clinical epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

63

2

Gastroenterology

2

2

49

3

Public Health

1

1

37

4

Diabetes

1

1

14

5

Epidemiology

1

1

37

Anna Fábián

×

20

Publications

408

Citations

13

H-Index

YearCitations

Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBD

Kelly Gatt, John Schembri, Dimitrios Christodoulou,

Journal of Crohn s and Colitis

2018

66

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Laurent Peyrin‐Biroulet, Jean‐François Rahier, Julien Kirchgesner,

Clinical Gastroenterology and Hepatology

2022

37

Pregnancy does not affect fecal calprotectin concentration in healthy women

Anita Bálint, Anna Berényi, Klaudia Farkas,

The Turkish Journal of Gastroenterology

2017

28

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Anita Bálint, Mariann Rutka, Zsuzsanna Végh,

Expert Opinion on Drug Safety

2017

28

Prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of solid pancreatic cancer

Renáta Bor, Béla Vasas, Anna Fábián,

BMC Gastroenterology

2019

27

Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome

Anita Bálint, Klaudia Farkas, Orsolya Méhi,

Pharmaceuticals

2020

25

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center

Klaudia Farkas, Mariann Rutka, Tamás Ferenci,

Expert Opinion on Biological Therapy

2017

24

Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum

Mariann Rutka, Renáta Bor, Anita Bálint,

Mediators of Inflammation

2016

21

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system

Anita Bálint, Klaudia Farkas, Zoltán Szepes,

BMC Gastroenterology

2018

15

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease: A Retrospective, Multicentre Study

B Farkas, Talat Bessissow, Jimmy K. Limdi,

Journal of Clinical Medicine

2024

15

Page 1